
Loading, please wait...

Loading, please wait...

A recent cross-sectional survey indicates that parents strongly support more transparent Non-Sugar Sweetener Labeling for products aimed at children. The study, conducted in August 2024, surveyed 1,047 U.S. parents of children aged 2-12 years. While many parents use non-sugar sweeteners (NSS) to reduce sugar intake, they remain cautious about their long-term safety for children. Consequently, the majority of respondents favored mandatory front-of-package labels (FOPL) to assist in making healthier choices.
The results showed that 82% of parents believe NSS help reduce their own sugar intake. However, only 58% viewed them as helpful for their children. Furthermore, while 61.4% considered occasional use safe for kids, only 21.9% felt daily consumption was appropriate. Parents specifically preferred a yellow triangle label stating \"Not recommended for children.\" This preference remained consistent across various demographic backgrounds and health statuses.
Clinicians should note that these findings align with recent World Health Organization (WHO) guidelines. The WHO currently advises against using NSS for weight management or reducing non-communicable disease risk. Therefore, pediatricians must guide families toward reducing overall sweetness in the diet rather than simply swapping sugar for additives. Specifically, natural sweeteners like stevia were perceived as safer by 60.5% of parents compared to only 26.6% for artificial variants. However, both types fall under the same WHO cautionary umbrella regarding long-term metabolic health.
In India, the Food Safety and Standards Authority of India (FSSAI) is also moving toward stricter labeling requirements. These regulations aim to enhance transparency and help consumers identify high sugar, salt, and fat content more effectively. For healthcare providers, this represents a vital opportunity to discuss dietary habits during routine check-ups. Encouraging water or whole fruits over sweetened beverages remains the gold standard for pediatric nutrition.
While 60.5% of parents in the study perceived natural sweeteners as safer, clinical guidelines from the WHO do not distinguish between natural and synthetic NSS regarding weight control. Both lack nutritional value and may maintain a preference for high sweetness in the diet.
Research indicates that 76.3% of parents support mandatory labeling. Specifically, they prefer a clear, child-focused warning, such as a yellow triangle stating the product is not recommended for children.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or establish a doctor-patient relationship. Refer to the latest local and national guidelines for clinical practice.
References
Grilo MF et al. U.S. Parents' Perceptions of Non-Sugar Sweeteners and Non-Sugar Sweetener Front-Of-Package Labels for Children. Am J Health Promot. 2026 Apr 13. doi: 10.1177/08901171261442056. PMID: 41974045.
World Health Organization. Use of non-sugar sweeteners: WHO guideline. Geneva: World Health Organization; 2023.
Food Safety and Standards Authority of India (FSSAI). Note on Non Sugar Sweeteners (NSS) & Aspartame: Highlights of the WHO Report. 2023.
"
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A 2024 survey of 1,047 parents reveals strong support for child-focused front-of-package labels on products containing non-sugar sweeteners (NSS)....
4 months ago

Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today